Straumann Holding AG engages in the provision of implant, restorative, and regenerative dentistry solutions to dental professionals and laboratories. The company is headquartered in Basel, Basel-Stadt and currently employs 11,948 full-time employees. In collaboration with clinics, research institutes and universities, the Group researches and develops implants, instruments, computer-aided design/manufacturing (CAD/CAM) prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann Holding AG also offers a range of services to the dental profession worldwide, including training and education, provided in collaboration with the International Team for Implantology (ITI). Its products and services are available in a number of countries through the Group’s headquarters and through a network of subsidiaries and technology partners located in Europe, North America, the Asia/Pacific region and in Latin America, including Dental Wings Inc based in Canada and Createch Medical SL based in Spain.
Straumann Holding AG tiene un dividendo anual de 1.16 por acción, con un rendimiento del 0.00%. El dividendo se paga anualmente y la última fecha ex-dividendo fue Apr 14, 2025.